Inhibiting DNA methylation activates cancer testis antigens and expression of the antigen processing and presentation machinery in colon and ovarian cancer cells.
Innovative therapies for solid tumors are urgently needed. Recently, therapies that harness the host immune system to fight cancer cells have successfully treated a subset of patients with solid tumors. These responses have been strong and durable but observed in subsets of patients. Work from our g...
Main Authors: | Cornelia Siebenkäs, Katherine B Chiappinelli, Angela A Guzzetta, Anup Sharma, Jana Jeschke, Rajita Vatapalli, Stephen B Baylin, Nita Ahuja |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0179501&type=printable |
Similar Items
-
Characterization of Cancer/Testis Antigens as Prognostic Markers of Ovarian Cancer
by: Ramilia Vlasenkova, et al.
Published: (2023-09-01) -
Inhibiting DNA methylation improves antitumor immunity in ovarian cancer
by: Katherine B. Chiappinelli, et al.
Published: (2022-07-01) -
Cancer-testis antigens in ovarian cancer: implication for biomarkers and therapeutic targets
by: Kaipeng Xie, et al.
Published: (2019-01-01) -
CANCER TESTIS ANTIGENS IN CANCER IMMUNOTHERAPY
by: D. I. Vodolazhsky, et al.
Published: (2017-06-01) -
Hypomethylating agents synergize with irinotecan to improve response to chemotherapy in colorectal cancer cells.
by: Anup Sharma, et al.
Published: (2017-01-01)